Accessibility Menu
Nanalysis Scientific logo

Nanalysis Scientific

(OTC) NSCIF

Current Price$0.09
Market Cap$12.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-76%
5 Year-92%
1 Year-48%
1 Month+1%
Nanalysis Scientific last closing stock price
MetricPriceDate
Last closeUSD 0.092026-07-16
Nanalysis Scientific stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.4%USD 0.092026-07-06
1 month+0.85%USD 0.092026-06-16
3 month-14.67%USD 0.112026-04-15
Year to date-19.25%USD 0.112025-12-29
1 year-47.89%USD 0.172025-07-16
3 year-80.33%USD 0.462023-07-17
5 year-91.64%USD 1.082021-07-16
Since inception-76.17%USD 0.392020-04-16

Nanalysis Scientific Financials at a Glance

Market Cap

$12.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$40.23M

Net Income (TTM)

-CA$5.64M

EPS (TTM)

-$0.03

P/E Ratio

-2.72

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$0.09

Volume

520

Open

$0.09

Previous Close

$0.09

Daily Range

$0.09 - $0.09

52-Week Range

$0.08 - $0.18

Estimated Earnings Date

Aug 20, 2026

NSCIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nanalysis Scientific

Nanalysis Scientific Corp. develops and sells advanced magnetic resonance technology products across various global markets. The company operates in two segments: Scientific Equipment and Security Services, catering to diverse industries including pharmaceuticals, biotechnology, and education.

Products and Services
  • Nuclear magnetic resonance (NMR) spectrometers for scientific research
  • Software solutions for data acquisition and analysis in magnetic resonance
  • Security services including maintenance and installation of detection equipment
Growth Outlook
  • Revenue of CAD 10.69 million in Q1 2026 shows consistent demand
  • Gross profit margin improved to 14.6% in Q1 2026 from 12.5% in Q4 2025
  • Expansion into international markets is expected to drive future growth
Financial Highlights
  • Net income of CAD -1.28 million in Q1 2026 reflects ongoing investment in growth
  • Operating expenses decreased by 10% compared to Q4 2025
  • Current ratio of 1.02 indicates stable liquidity position
Nanalysis Scientific Corp. is positioned in a niche market with significant growth potential. The company's focus on innovative magnetic resonance technology and software solutions aligns with increasing demand in various sectors. Recent financial performance indicates a commitment to improving operational efficiency, as evidenced by the reduction in operating expenses. The positive trend in gross profit margin suggests that the company is effectively managing its costs while pursuing growth opportunities. With a solid foundation and strategic expansion plans, Nanalysis Scientific Corp. presents an intriguing opportunity for investors interested in the healthcare technology sector.
AI Generated • Jul 13, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

240

CEO

Sean Krakiwsky

Website

www.nanalysis.com

Headquarters

Calgary, AB T2E 7C3, CA

NSCIF Financials

Key Financial Metrics (TTM)

Gross Margin

21.89%

Operating Margin

-8.89%

Net Income Margin

-14.01%

Return on Equity

-44.82%

Return on Capital

-12.15%

Return on Assets

-16.06%

Earnings Yield

-36.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

138.46M

Volume

520

Avg. Volume

4.77K

Financials (TTM)

Gross Profit

CA$8.81M

Operating Income

-CA$3.58M

EBITDA

-CA$872.97K

Operating Cash Flow

CA$472.23K

Capital Expenditure

-CA$1.33M

Free Cash Flow

-CA$859.87K

Cash & ST Invst.

CA$732.89K

Total Debt

CA$14.91M

Nanalysis Scientific Performance Analysis

Nanalysis Scientific annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 19,065,89449.0%
20232023-12-31CAD 21,090,81610.6%
20242024-12-31CAD 33,208,96057.5%
20252025-12-31CAD 28,720,624-13.5%
Nanalysis Scientific sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-9.6%
Q32025-09-30-3.0%
Q42025-12-3115.0%
Q12026-03-310.2%
Nanalysis Scientific annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.08276.1%
20232023-12-31CAD -0.1260.1%
20242024-12-31CAD -0.09-25.8%
20252025-12-31CAD -0.04-60.7%
Nanalysis Scientific sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-100.0%
Q32025-09-3034.5%
Q42025-12-3158.0%
Q12026-03-31-72.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$10.69M

+0.9%

Gross Profit

CA$1.56M

-42.7%

Gross Margin

14.56%

N/A

Market Cap

$12.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$833.36

N/A

Employees

15,299

N/A

Net Income

-CA$1.28M

+1.7%

EBITDA

CA$13.03K

+534.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$732.89K

+3.7%

Total Debt

CA$14.91M

-6.9%

Accounts Receivable

CA$8.65M

+4.9%

Inventory

CA$3.81M

-17.6%

Long Term Debt

CA$7.29M

+23.9%

Short Term Debt

CA$7.60M

-25.0%

Return on Assets

-16.06%

N/A

Return on Invested Capital

-17.05%

N/A

Free Cash Flow

-CA$337.87K

-116.2%

Operating Cash Flow

-CA$300.78K

-111.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
YNVYFYnvisible Interactive Inc.
$0.06-8.53%
SDCHSideChannel, Inc.
$1.85-5.13%
BNSOFBonso Electronics International Inc.
$1.68-29.71%
QURTQuarta-Rad, Inc.
$0.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.60-0.00%
ATAIAtaiBeckley
$7.15+0.33%
NOKNokia
$10.38-0.08%
ONDSOndas
$6.65-0.06%

Questions About NSCIF

What is the current price of Nanalysis Scientific?

Nanalysis Scientific is trading at $0.09 per share.

What is the 52-week range for Nanalysis Scientific?

Over the past 52 weeks, Nanalysis Scientific has traded between $0.08 and $0.18.

How much debt does Nanalysis Scientific have?

As of the most recent reporting period, Nanalysis Scientific reported total debt of CA$10.65M.

How much cash does Nanalysis Scientific have on hand?

Nanalysis Scientific reported CA$523.81K in cash and cash equivalents in its most recent financial results.

What is Nanalysis Scientific’s dividend yield?

Nanalysis Scientific does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services